We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Sanofi Pasteur’s new combined Quadracel DTaP plus polio vaccine is about to hit the U.S. market for children four to six years old, following FDA approval Wednesday.